Legend Biotech (LEGN) Profit After Tax (QoQ) (2019 - 2026)
Legend Biotech (LEGN) Profit After Tax (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Legend Biotech | 7.11 Bn | 6.46 Bn | 129.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -275.73% |
| Dec 31, 2025 | 177.86% |
| Sep 30, 2025 | 68.35% |
| Jun 30, 2025 | -24.14% |
| Mar 31, 2025 | -482.58% |
| Dec 31, 2024 | 121.07% |
| Sep 30, 2024 | -588.73% |
| Jun 30, 2024 | 62.09% |
| Mar 31, 2024 | -33,040.22% |
| Dec 31, 2023 | 99.77% |
| Sep 30, 2023 | 68.76% |
| Jun 30, 2023 | -77.63% |
| Mar 31, 2023 | 17.50% |
| Dec 31, 2022 | -59.94% |
| Sep 30, 2022 | 55.96% |
| Jun 30, 2022 | -503.55% |
| Mar 31, 2022 | 62.27% |
| Dec 31, 2021 | 32.09% |
| Sep 30, 2021 | 27.63% |
| Jun 30, 2021 | -174,579.35% |